HWKN · Insider Trading
Hawkins Inc
Every open-market purchase and sale reported by HWKN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Jeffrey P. Oldenkamp | EXECUTIVE VP AND CFO | Buy | +1,290 | +$153.51K |
| 2026-08-27 | Douglas A. Lange | VP - WATER TREATMENT GROUP | Buy | +910 | +$108.07K |
| 2026-08-11 | Patrick H. Hawkins | CEO AND PRESIDENT | G | −580 | — |
| 2026-07-31 | Yi Tang | Director | A | +721 | — |
| 2026-07-31 | Mary J. Schumacher | Director | A | +721 | — |
| 2026-07-31 | James A Faulconbridge | Director | A | +721 | — |
| 2026-07-31 | Jeffrey E Spethmann | Director | A | +721 | — |
| 2026-07-31 | Jeffrey L Wright | Director | A | +721 | — |
| 2026-07-31 | James T Thompson | Director | A | +721 | — |
| 2026-07-31 | Daniel J Stauber | Director | A | +721 | — |
| 2026-05-15 | Jeffrey P. Oldenkamp | EXECUTIVE VP AND CFO | A | +8,435 | — |
| 2026-05-15 | Gregory Alan Jones | VP of Food and Health Sciences | A | +1,970 | — |
| 2026-05-15 | Patrick H. Hawkins | CEO AND PRESIDENT | A | +16,934 | — |
| 2026-05-15 | Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | A | +2,697 | — |
| 2026-05-15 | David J. Mangine | VP-INDUSTRIAL SOLUTIONS GROUP | A | +1,906 | — |
| 2026-05-15 | Shirley A. Rozeboom | VP HEALTH AND NUTRITION | MIXED | −1,702 | −$547.04K |
| 2026-05-15 | Douglas A. Lange | VP - WATER TREATMENT GROUP | A | +1,994 | — |
| 2026-04-01 | Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | F | −3,818 | −$578.89K |
| 2026-04-01 | Jeffrey P. Oldenkamp | EXECUTIVE VP AND CFO | F | −5,675 | −$860.44K |
| 2026-04-01 | Patrick H. Hawkins | CEO AND PRESIDENT | F | −10,950 | −$1.66M |
| 2026-04-01 | David J. Mangine | VP-INDUSTRIAL SOLUTIONS GROUP | F | −3,493 | −$529.61K |
| 2026-04-01 | Douglas A. Lange | VP - WATER TREATMENT GROUP | F | −3,855 | −$584.50K |
| 2026-02-25 | Patrick H. Hawkins | CEO AND PRESIDENT | G | −780 | — |
| 2026-02-06 | James A Faulconbridge | Director | Buy | +3,000 | +$388.86K |
| 2025-12-11 | Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | G | −1,460 | −$184.46K |
| 2025-11-14 | Richard G Erstad | VP, GENERAL COUNSEL & SEC | G | −50 | — |
| 2025-11-05 | Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | Buy | +1,587 | +$200.51K |
| 2025-09-08 | Patrick H. Hawkins | CEO AND PRESIDENT | G | −220 | — |
| 2025-08-01 | James T Thompson | Director | A | +628 | — |
| 2025-08-01 | Mary J. Schumacher | Director | A | +628 | — |
| 2025-08-01 | Yi Tang | Director | A | +628 | — |
| 2025-08-01 | Daniel J Stauber | Director | A | +628 | — |
| 2025-08-01 | James A Faulconbridge | Director | A | +628 | — |
| 2025-08-01 | Jeffrey L Wright | Director | A | +628 | — |
| 2025-08-01 | Jeffrey E Spethmann | Director | A | +628 | — |
| 2025-05-16 | Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | A | +5,035 | — |
| 2025-05-16 | Shirley A. Rozeboom | VP HEALTH AND NUTRITION | A | +3,553 | — |
| 2025-05-16 | Patrick H. Hawkins | CEO AND PRESIDENT | A | +22,114 | — |
| 2025-05-16 | Gregory Alan Jones | VP of Food and Health Sciences | A | +3,411 | — |
| 2025-05-16 | David J. Mangine | VP-INDUSTRIAL SOLUTIONS GROUP | A | +3,553 | — |
| 2025-05-16 | Douglas A. Lange | VP - WATER TREATMENT GROUP | A | +3,553 | — |
| 2025-05-16 | Jeffrey P. Oldenkamp | EXECUTIVE VP AND CFO | A | +15,757 | — |
| 2025-05-16 | Richard G Erstad | VP, GENERAL COUNSEL & SEC | A | +4,442 | — |
| 2025-04-14 | Douglas A. Lange | VP - WATER TREATMENT GROUP | F | −2,575 | −$272.74K |
| 2025-04-14 | Patrick H. Hawkins | CEO AND PRESIDENT | F | −9,549 | −$1.01M |
| 2025-04-14 | Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | F | −2,951 | −$312.57K |
| 2025-04-14 | Shirley A. Rozeboom | VP HEALTH AND NUTRITION | F | −3,152 | −$333.86K |
| 2025-04-14 | David J. Mangine | VP - INDUSTRIAL GROUP | F | −2,574 | −$272.64K |
| 2025-04-14 | Richard G Erstad | VP, GENERAL COUNSEL & SEC | F | −3,580 | −$379.19K |
| 2025-04-14 | Jeffrey P. Oldenkamp | EXECUTIVE VP AND CFO | F | −4,209 | −$445.82K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Patrick H. Hawkins | CEO AND PRESIDENT | 347,341 | $45.02M |
| Jeffrey P. Oldenkamp | EXECUTIVE VP AND CFO | 105,784 | $13.71M |
| Richard G Erstad | VP, GENERAL COUNSEL & SEC | 67,231 | $8.71M |
| James A Faulconbridge | Director | 53,128 | $6.89M |
| Jeffrey L Wright | Director | 42,916 | $5.56M |
| James T Thompson | Director | 38,916 | $5.04M |
| Drew M. Grahek | VICE PRESIDENT OF OPERATIONS | 38,040 | $4.93M |
| David J. Mangine | VP-INDUSTRIAL SOLUTIONS GROUP | 37,543 | $4.87M |
| Daniel J Stauber | Director | 35,497 | $4.60M |
| Shirley A. Rozeboom | VP HEALTH AND NUTRITION | 31,959 | $4.14M |
| Douglas A. Lange | VP - WATER TREATMENT GROUP | 29,110 | $3.77M |
| Mary J. Schumacher | Director | 26,898 | $3.49M |
| Gregory Alan Jones | VP of Food and Health Sciences | 10,144 | $1.31M |
| Yi Tang | Director | 8,612 | $1.12M |
| Jeffrey E Spethmann | Director | 6,639 | $860.43K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HWKN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.